Target intelligence / Profile preview

G protein-activated inward rectifier potassium channel 2 (Kir3.2)

Target
Kir3.2
Molecular classification
Ion channel, Inward rectifier potassium channel, G protein-activated ion channel
01

Overview

G protein-activated inward rectifier potassium channel 2 (GIRK2 or Kir3.2) is an inwardly rectifying potassium channel encoded by the KCNJ6 gene[4][6][7]. GIRK2 forms homo- or heterotetrameric complexes, often with other GIRK (Kir3.x) subunits, and is activated by Gβγ subunits released from activated G protein-coupled receptors (GPCRs)[4]. It plays a critical role in stabilizing the resting membrane potential and in mediating inhibitory synaptic transmission in neurons, as well as regulating heart rate in cardiac myocytes[4][5][6]. Dysfunction or altered trafficking and gating of Kir3.2 channels can lead to pathologies including epilepsy, movement disorders, and cardiac arrhythmias, and they are a key therapeutic target for modulating neuronal excitability in neuropsychiatric and neurologic disease[6]. Drugs can target Kir3.2 directly or indirectly via their regulation by GPCRs (such as GABAB, muscarinic, and opioid receptors), and safety concerns include the risk of excessive inhibition of neuronal or cardiac excitability[6][4].

Other names
GIRK2KCNJ6G protein-coupled inwardly rectifying potassium channel 2Inward rectifier potassium channel 6
02

Mechanism of action

Channel openers (enhance potassium efflux and neuronal inhibition), Channel blockers (reduce potassium efflux and increase excitability), allosteric modulation, G protein-mediated activation via GPCRs

03

Biological functions

Regulation of neuronal excitabilityHeart rate controlNeuronal signalingInhibition of neurotransmissionModulation of pain and memory
04

Disease associations

EpilepsyDown syndromeSchizophreniaNeurodegenerative diseaseCardiac arrhythmiasOther neurological disorders
05

Safety considerations

CNS depressionCardiac rhythm disturbancesPotential proconvulsant effectsHypotensionOff-target ion channel modulation
06

Interacting drugs

Ethanol

6 more in the full profile.

Beyond the preview

Go deeper on G protein-activated inward rectifier potassium channel 2 (Kir3.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-activated inward rectifier potassium channel 2 (Kir3.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call